Model
Edge
Alnylam Pharmaceuticals, Inc.
0001511797
Filing type
3
Filing date
Sep 21, 2025
Updated
Sep 22, 2025 ยท 2:04 PM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership